Form 4: Artivion VP Andrew Green Reports Stock Transactions Following Performance Stock Unit Vesting

Andrew Green, VP of Regulatory at Artivion, Inc., reports the acquisition and disposal of common stock related to the vesting of performance stock units, with sales executed to cover tax withholding obligations.

Summary

• On February 23, 2024, Andrew Green, VP of Regulatory at Artivion, acquired 3,366 shares of common stock related to performance stock units granted on February 22, 2023.
• An additional 6,914 shares were acquired on the same day related to a separate tranche of performance stock units granted on February 22, 2023.
• On February 26, 2024, Green sold 1,185 shares at a price of $20.2711 per share and 1,218 shares at a price of $20.2711 per share.
• These sales were executed to cover tax withholding obligations arising from the vesting of the performance stock units.
• Following these transactions, Green directly owns 44,544 shares of Artivion common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transactions are related to standard executive compensation practices and tax obligations.

Positives

• The vesting of performance stock units indicates that performance goals were likely met, which could be seen as a positive signal.

Negatives

• The sale of shares, even for tax purposes, could be interpreted negatively by some investors, although it's a common practice.

Risks

• Executive stock sales, even for tax purposes, can sometimes create short-term price volatility.

Future Outlook

The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies, often tied to compensation packages and equity-based incentives.

Comparison to Industry Standards

• Executive compensation packages often include performance-based equity grants, aligning management's interests with those of shareholders.
• Companies like Medtronic, Abbott, and Boston Scientific also utilize similar equity compensation strategies for their executives.
• The 'sell to cover' practice for tax obligations is a standard procedure among executives receiving equity compensation.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the potential for short-term price fluctuations.

Key Dates